Purpose

The purpose of this study is to determine the effect of decreased insufflation pressure on postoperative pain, analgesic use, and surgical safety and feasibility for laparoscopic hysterectomy.

Condition

Eligibility

Eligible Ages
Between 18 Years and 80 Years
Eligible Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Women aged 18 to 80 - BMI 55.0 or less - Laparoscopic hysterectomy surgery planned

Exclusion Criteria

  • Women younger than 18 or older than 80 years of age - BMI over 55.0 - Laparoscopic hysterectomy surgery not planned

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Single (Participant)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
12 mmHg Insufflation Pressure
Participants received 12 mmHg of insufflation pressure during their laparoscopic hysterectomy.
  • Procedure: Lower Insufflation Pressure
    Participants underwent laparoscopic hysterectomy with an insufflation pressure that is lower than the standard insufflation pressure used in this type of surgery.
Active Comparator
15 mmHg Insufflation Pressure
Participants received 15 mmHg of insufflation pressure during their laparoscopic hysterectomy.
  • Procedure: Standard Insufflation Pressure
    Participants underwent laparoscopic hysterectomy with a standard insufflation pressure.

Recruiting Locations

University of Tennessee Health Science Center
Memphis, Tennessee 38103
Contact:
Amira Wohabrebbi, PhD
901-545-7453
awohabre@uthsc.edu

More Details

Status
Recruiting
Sponsor
University of Tennessee

Study Contact

Detailed Description

This is a prospective, single-blinded, randomized clinical trial in which participants undergoing laparoscopic hysterectomy will be randomized in a 1:1 ratio to undergo surgery with peritoneal insufflation pressure set to 15 mmHg (standard) or 12 mmHg (comparison). Randomization was performed using computer-generated permuted blocks of four participants. All participants on the first postoperative day will be asked to rate their pain with a Visual Analog Scale (VAS). At a postoperative visit 2 weeks after surgery, all participants will be asked to complete the VAS again. The highest preoperative pain (up to 2 hours before surgery) and immediate postoperative pain, using the VAS, in the post anesthesia care unit (PACU) will be recorded. All participants will be planned for discharge from PACU. Age, body mass index, gynecologic diagnosis, medical history, and preoperative analgesia or opioid use will be extracted from the medical records by trained research staff and entered into a secure electronic database. Preoperative analgesia and opioid saw will be verified with active prescription records at the time of surgery. After surgery, analgesic doses, operative time, additional procedures performed, conversion to laparotomy or increased insufflation pressure, estimated blood loss, and length of stay will be recorded.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.